NZ527991A - Carbamate compounds for use in preventing or treating psychotic disorders - Google Patents

Carbamate compounds for use in preventing or treating psychotic disorders

Info

Publication number
NZ527991A
NZ527991A NZ527991A NZ52799102A NZ527991A NZ 527991 A NZ527991 A NZ 527991A NZ 527991 A NZ527991 A NZ 527991A NZ 52799102 A NZ52799102 A NZ 52799102A NZ 527991 A NZ527991 A NZ 527991A
Authority
NZ
New Zealand
Prior art keywords
formula
group
enantiomer
phenyl
schizophrenia
Prior art date
Application number
NZ527991A
Other languages
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NZ527991A publication Critical patent/NZ527991A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ527991A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders NZ527991A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number Publication Date
NZ527991A true NZ527991A (en) 2005-04-29

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ527991A NZ527991A (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Country Status (25)

Country Link
US (1) US6541513B2 (cg-RX-API-DMAC7.html)
EP (1) EP1401424B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276841B2 (cg-RX-API-DMAC7.html)
KR (1) KR100886578B1 (cg-RX-API-DMAC7.html)
CN (1) CN1262271C (cg-RX-API-DMAC7.html)
AR (1) AR032876A1 (cg-RX-API-DMAC7.html)
AT (1) ATE346597T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002242296B2 (cg-RX-API-DMAC7.html)
BR (1) BR0207829A (cg-RX-API-DMAC7.html)
CA (1) CA2439480C (cg-RX-API-DMAC7.html)
CZ (1) CZ302412B6 (cg-RX-API-DMAC7.html)
DE (1) DE60216457T2 (cg-RX-API-DMAC7.html)
DK (1) DK1401424T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275844T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303342A3 (cg-RX-API-DMAC7.html)
IL (2) IL157588A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007722A (cg-RX-API-DMAC7.html)
NO (1) NO20033801L (cg-RX-API-DMAC7.html)
NZ (1) NZ527991A (cg-RX-API-DMAC7.html)
PL (1) PL365021A1 (cg-RX-API-DMAC7.html)
PT (1) PT1401424E (cg-RX-API-DMAC7.html)
RS (1) RS51056B (cg-RX-API-DMAC7.html)
RU (1) RU2302240C2 (cg-RX-API-DMAC7.html)
TW (1) TWI251486B (cg-RX-API-DMAC7.html)
WO (1) WO2002067927A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2003007934A1 (en) 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MXPA03007720A (es) 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
DE60220043T2 (de) * 2001-02-27 2008-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
JP2010508354A (ja) * 2006-10-31 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 広汎性発達障害の処置
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
WO2014142547A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
EP0480939B1 (en) * 1989-06-09 1995-01-25 The Upjohn Company Heterocyclic amines having central nervous system activity
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ302412B6 (cs) 2011-05-04
NO20033801D0 (no) 2003-08-26
CZ20032297A3 (cs) 2004-06-16
HUP0303342A3 (en) 2012-07-30
RS67503A (sr) 2006-12-15
DK1401424T3 (da) 2007-02-26
AU2002242296B2 (en) 2006-06-29
CN1505507A (zh) 2004-06-16
JP2004523556A (ja) 2004-08-05
DE60216457D1 (de) 2007-01-11
RS51056B (sr) 2010-10-31
RU2003128983A (ru) 2005-03-10
US20020165272A1 (en) 2002-11-07
WO2002067927A1 (en) 2002-09-06
MXPA03007722A (es) 2004-11-12
AR032876A1 (es) 2003-11-26
IL157588A0 (en) 2004-03-28
ES2275844T3 (es) 2007-06-16
KR100886578B1 (ko) 2009-03-05
PT1401424E (pt) 2007-02-28
RU2302240C2 (ru) 2007-07-10
ATE346597T1 (de) 2006-12-15
KR20030076713A (ko) 2003-09-26
HUP0303342A2 (hu) 2004-01-28
JP4276841B2 (ja) 2009-06-10
EP1401424B1 (en) 2006-11-29
EP1401424A1 (en) 2004-03-31
DE60216457T2 (de) 2007-09-20
TWI251486B (en) 2006-03-21
US6541513B2 (en) 2003-04-01
NO20033801L (no) 2003-10-22
CN1262271C (zh) 2006-07-05
CA2439480C (en) 2011-04-26
PL365021A1 (en) 2004-12-27
BR0207829A (pt) 2004-06-22
IL157588A (en) 2009-12-24
CA2439480A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
RU2338537C2 (ru) СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
KR101335941B1 (ko) 수면-각성 장애의 치료
AU2010206886B2 (en) Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
AU2002242296B2 (en) Carbamate compounds for use in preventing or treating psychotic disorders
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
HK1247847A1 (zh) 四氢-N,N-二甲基-2,2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途
RS50676B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
TWI250872B (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2005335241B2 (en) Methods for treating substance-related disorders
ES2656313T3 (es) Uso de derivados de amida cíclica para tratar trastornos del sueño
MXPA03007720A (es) Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
EP3302493B1 (en) Inhibitors of cystine-glutamate transporter for use in treating or preventing substance-related and addictive disorders
EP3096790B1 (en) Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
ES2285245T3 (es) Tratamiento de la disquinesia con 2,3-benzodiazapinas.
US20020137767A1 (en) Methods for treating addictive disorders

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)